171 related articles for article (PubMed ID: 32347177)
21. Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.
Murray A; Lourenco T; de Verteuil R; Hernandez R; Fraser C; McKinley A; Krukowski Z; Vale L; Grant A
Health Technol Assess; 2006 Nov; 10(45):1-141, iii-iv. PubMed ID: 17083853
[TBL] [Abstract][Full Text] [Related]
22. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
23. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
[TBL] [Abstract][Full Text] [Related]
24. ICER, ISPOR AND QALYs: Tales of Imaginary Worlds.
Langley PC
Innov Pharm; 2019; 10(4):. PubMed ID: 34007578
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
Yoon AP; Kane RL; Hutton DW; Chung KC
JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
[TBL] [Abstract][Full Text] [Related]
26. Cost-utility analysis of total shoulder arthroplasty: a prospective health economic study using real-world data.
Grobet CE; Glanzmann MC; Eichler K; Rickenbacher D; Meier F; Brunner B; Audigé L
J Shoulder Elbow Surg; 2021 Sep; 30(9):1998-2006. PubMed ID: 33774171
[TBL] [Abstract][Full Text] [Related]
27. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
28. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
30. Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model.
Tappenden P; Carroll C; Hamilton J; Kaltenthaler E; Wong R; Wadsley J; Moss L; Balasubramanian S
Health Technol Assess; 2019 Feb; 23(8):1-144. PubMed ID: 30821231
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
[TBL] [Abstract][Full Text] [Related]
33. Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal.
Tikhonova IA; Hoyle MW; Snowsill TM; Cooper C; Varley-Campbell JL; Rudin CE; Mujica Mota RE
Pharmacoeconomics; 2017 Mar; 35(3):363-373. PubMed ID: 27752999
[TBL] [Abstract][Full Text] [Related]
34. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
[TBL] [Abstract][Full Text] [Related]
35. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
[TBL] [Abstract][Full Text] [Related]
36. Nonsense on Stilts - Part 1: The ICER 2020-2023 Value Assessment Framework for Constructing Imaginary Worlds.
Langley PC
Innov Pharm; 2020; 11(1):. PubMed ID: 34017624
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.
Ito K; Chapman R; Pearson SD; Tafazzoli A; Yaffe K; Gurwitz JH
JAMA Netw Open; 2021 Oct; 4(10):e2129392. PubMed ID: 34677596
[TBL] [Abstract][Full Text] [Related]
38. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
[TBL] [Abstract][Full Text] [Related]
39. Value-Based Pricing for Emerging Gene Therapies: The Economic Case for a Higher Cost-Effectiveness Threshold.
Garrison LP; Jackson T; Paul D; Kenston M
J Manag Care Spec Pharm; 2019 Jul; 25(7):793-799. PubMed ID: 30784347
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
